AKRIBION Trademark

Trademark Overview


On Wednesday, October 26, 2022, a trademark application was filed for AKRIBION with the United States Patent and Trademark Office. The USPTO has given the AKRIBION trademark a serial number of 79361574. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by BRAIN Biotech AG. The AKRIBION trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Recycling of waste and trash; air purification and treatment of water; food and drink preservation; processing of biological materials, namely, batch biological treatment services; waste treatment; joining of materials or substances, namely, custom additive manufacturing for others; treatment of hazardous substances, namely, waste, gases and liquids; treatment of materials using biotechnological method, namely, bio-hazard biological decontamination services

Medical services based on biotechnological methods; veterinary services based on biotechnological methods; hygienic and beauty care for human beings and animals based on biotechnological methods; agriculture, horticulture and forestry services, namely, cultivation of agricultural plants for others, horticultural services, and forest habitat restoration, all based on biotechnological methods; regenerative medicine services; medical analysis services for diagnostic and treatment purposes by medical laboratories; medical treatment with cultured cells; medical screening; animal breeding; DNA screening for medical purposes; conducting medical analysis by a medical laboratory for the purpose of the treatment of persons; health care for people; medical analysis services relating to the treatment of persons; medical analysis for the diagnosis and treatment of persons; medical diagnostic testing and analysis services; medical services; medical services in the field of diabetes; medical and heal...

Testing of materials; quality control for others; biological analysis; biological research; biological laboratory services; biological research and analysis; biological research; clinical research in the field of pharmaceuticals and medical research; research services, namely, scientific research; provision of research services, namely, product research; biomedical research services; industrial research in the field of pharmaceuticals; medical research; pharmaceutical research services; genetic research; research relating to biotechnology; providing information relating to scientific research in the fields of biochemistry and biotechnology; scientific research; technical research, namely, biochemistry research services, biotechnology research services, Research in the field of DNA repair technology, RNA interference technology research, Research in the field of gene editing technology ; chemical research and analysis services; medical, biopharmaceutical and biotechnological research la...
akribion

General Information


Serial Number79361574
Word MarkAKRIBION
Filing DateWednesday, October 26, 2022
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383363
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements


Goods and ServicesRecycling of waste and trash; air purification and treatment of water; food and drink preservation; processing of biological materials, namely, batch biological treatment services; waste treatment; joining of materials or substances, namely, custom additive manufacturing for others; treatment of hazardous substances, namely, waste, gases and liquids; treatment of materials using biotechnological method, namely, bio-hazard biological decontamination services
Goods and ServicesMedical services based on biotechnological methods; veterinary services based on biotechnological methods; hygienic and beauty care for human beings and animals based on biotechnological methods; agriculture, horticulture and forestry services, namely, cultivation of agricultural plants for others, horticultural services, and forest habitat restoration, all based on biotechnological methods; regenerative medicine services; medical analysis services for diagnostic and treatment purposes by medical laboratories; medical treatment with cultured cells; medical screening; animal breeding; DNA screening for medical purposes; conducting medical analysis by a medical laboratory for the purpose of the treatment of persons; health care for people; medical analysis services relating to the treatment of persons; medical analysis for the diagnosis and treatment of persons; medical diagnostic testing and analysis services; medical services; medical services in the field of diabetes; medical and health care services; medical and health care services relating to DNA, genetics and genetic testing; medical services for the treatment of the skin; medical services for the treatment of diseases of the human body; medical care and analysis services relating to the treatment of patients; providing information relating to medical services
Goods and ServicesTesting of materials; quality control for others; biological analysis; biological research; biological laboratory services; biological research and analysis; biological research; clinical research in the field of pharmaceuticals and medical research; research services, namely, scientific research; provision of research services, namely, product research; biomedical research services; industrial research in the field of pharmaceuticals; medical research; pharmaceutical research services; genetic research; research relating to biotechnology; providing information relating to scientific research in the fields of biochemistry and biotechnology; scientific research; technical research, namely, biochemistry research services, biotechnology research services, Research in the field of DNA repair technology, RNA interference technology research, Research in the field of gene editing technology ; chemical research and analysis services; medical, biopharmaceutical and biotechnological research laboratories; research and development of new products for others; computer aided scientific research services; computer aided industrial research services in the field of pharmaceuticals, biotechnology and medicine; biochemical research and analysis; scientific research relating to biology; biotechnological research; biotechnological research relating to industry; scientific and industrial research in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; scientific research for medical purposes; industrial analysis and research services in the field of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; medical and pharmacological research services; biological research laboratory services; chemical research laboratory services; chemical research; pharmaceutical research and development; DNA screening for scientific research purposes; research to develop new products; research in the field of gene therapy; cell separation research services; biochemical research and development; research in the field of science provided by engineers; research and development services in the field of chemistry; scientific services, namely scientific investigations for medical and pharmaceutical purposes and medical research relating thereto; scientific research relating to genetics; research and development in the pharmaceutical and biotechnology fields; preparation of biological samples for analysis in research laboratories; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; consultancy in the field of industrial research relating to pharmaceuticals; consultancy in the field of scientific research; analysis of human tissues for medical research; preparation of biological samples for testing and analysis in research laboratories; research and development in the field of microorganisms and cells; biochemical analysis; scientific analysis in the field of biochemistry and biotechnology; technological analysis services, namely technological analysis of gene editing technology, RNA interference technology, DNA repair technology; chemical analysis; scientific research and analysis in the field of biochemistry; analysis in the field of molecular biology; scientific research in the field of genetics; genetic engineering; molecular biology research; scientific research in the field of DNA modification; industrial research in the field of DNA modification ; pharmaceutical research in the field of DNA modification; veterinary research in the field of DNA modification; medical research in the field of DNA modification; veterinary pharmaceutical research in the field of DNA modification; biological testing of materials; biochemical engineering services; biotechnological research relating to agriculture; biotechnological research relating to livestock; analysis services relating to the testing of chemical ingredients in liquids; analysis services relating to the determination of bacterial content in liquids; analysis services relating to the detection of bacterial content in liquids; bacteriological analysis; bacteriological research and analysis; bacteriological research and testing; advice on research in the field of pharmacogenetics; advice on pharmaceutical research and development; consultancy in the field of bacteriological research; consultancy services relating to technological research of gene editing technology, RNA interference technology, DNA repair technology, pharmaceuticals, biotechnology and medicine; consultancy services relating to scientific research; biochemical analysis; biochemical research service; biotechnical research in the industrial sector, namely, biotechnical research in the field of pharmaceuticals; computer-aided industrial analysis services in the field of pharmaceuticals; computer-aided scientific analysis in the field of pharmaceuticals; medical research laboratory services; medical laboratory services; DNA verification for scientific research purposes; conducting chemical research; research in the field of biotechnology; research in the field of medicine; research in the medical field; research on biotechnology; research on chemistry; research and development in the field of bacteriology; research and testing in the fields of bacteriology and virology; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; research and development services in the field of microorganisms and cells; research work of engineers in the technological field, namely, research in the field of genetic engineering; scientific research work by engineers; research for the development of new products; medical research services; pharmaceutical research; pharmaceutical development; technical research services, namely, product research; scientific services, namely, scientific laboratory services and related scientific research; scientific research in the field of bacteriology; scientific research in the field of pharmacy; scientific research in biology; scientific research in the field of genetics and genetic engineering; scientific research and development of new products for others; scientific research using databases; scientific research services; scientific and technological services, namely, scientific laboratory and software development in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; research and design of new products in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; industrial analysis and research services in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; design and development of computer software for use in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; consultancy and information in relation to the aforesaid services

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBRAIN Biotech AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameBRAIN Biotech AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameBRAIN Biotech AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, February 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 7, 2023APPLICATION FILING RECEIPT MAILED
Monday, February 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 13, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, February 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023ASSIGNED TO EXAMINER
Friday, August 18, 2023NON-FINAL ACTION WRITTEN
Saturday, August 19, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 11, 2023REFUSAL PROCESSED BY MPU
Monday, September 11, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 4, 2023REFUSAL PROCESSED BY IB
Wednesday, November 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 20, 2023FINAL REFUSAL WRITTEN
Wednesday, December 20, 2023FINAL REFUSAL E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 16, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 27, 2024NOTIFICATION PROCESSED BY IB
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, September 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 4, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 14, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED